4.6 Letter

A phase II trial of TBL-12 sea cucumber extract in patients with untreated asymptomatic myeloma

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 180, Issue 2, Pages 296-298

Publisher

WILEY
DOI: 10.1111/bjh.14314

Keywords

myeloma; myeloma therapy; cancer; risk factors

Categories

Funding

  1. Array BioPharma
  2. Novartis
  3. Millennium/Takeda
  4. Celgene
  5. Amgen-Onyx
  6. Janssen

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available